Sutent 12.5mg Capsule is a targeted therapy medication used to treat certain types of cancer. Its active ingredient, sunitinib, is a tyrosine kinase inhibitor that works by blocking the signals that cancer cells need to grow and divide. By inhibiting these signals, Sutent helps to slow down or stop the growth of tumors and can also inhibit the formation of new blood vessels that tumors need to survive.
Sutent is primarily indicated for the treatment of advanced renal cell carcinoma (kidney cancer), advanced gastrointestinal stromal tumors (GIST) after disease progression or intolerance to prior treatment, and advanced pancreatic neuroendocrine tumors (pNET) in patients with progressive disease.
The typical dosage and administration of Sutent should be strictly followed as prescribed by a healthcare professional. It is usually taken orally, once daily, with or without food. Dosage adjustments may be necessary based on individual response and tolerance.
Common side effects of Sutent can include fatigue, diarrhea, nausea, vomiting, hypertension, rash, and changes in hair and skin color. More serious side effects may occur, and patients should report any unusual symptoms to their doctor immediately. It is crucial to discuss potential risks and benefits with your oncologist before starting treatment.
Sutent 12.5mg Capsules should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
